Showing results (3971-3980 of 9,339) with videos related to
Sort By:
Pageof 934
Cancer Medicine|May 24, 2018
The effects of aberrant expression of LncRNA DGCR5/miR-873-5p/TUSC3 in lung cancer cell progressionJudong Luo, Hong Zhu, Hua Jiang, et al.Cancer Medicine|May 24, 2018
Genetically determined height was associated with lung cancer risk in East Asian populationLu Wang, Mingtao Huang, Hui Ding, et al.Cancer Medicine|May 24, 2018
Gemcitabine and cisplatin regimen facilitates prognosis of advanced nasopharyngeal carcinomaQiongxuan Li, Zhi Yin, Tingting Wang, et al.Cancer Medicine|June 15, 2017
Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United StatesYi Qian, Debajyoti Bhowmik, Christopher Bond, et al.Cancer Medicine|June 20, 2017
MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasionYadong Wu, Xiangjie Sun, Bin Song, et al.Cancer Medicine|May 17, 2018
Serum SP70 is a sensitive predictor of chemotherapy response in patients with advanced nonsmall cell lung cancerJingping Liu, Wei Zhang, Min Gu, et al.Cancer Medicine|May 18, 2018
Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancerXiaofei Zhu, Dongchen Shi, Fuqi Li, et al.Cancer Medicine|May 18, 2018
Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysisSophia C Kamran, Jeffrey W Clark, Hui Zheng, et al.Cancer Medicine|May 20, 2018
LGR5 promotes epithelial ovarian cancer proliferation, metastasis, and epithelial-mesenchymal transition through the Notch1 signaling pathwayWenxue Liu, Jing Zhang, Xupei Gan, et al.Cancer Medicine|April 27, 2018
Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseasesJin Bong Choi, Jung Ho Kim, Sung-Hoo Hong, et al.Pageof 934